Data indicating unequal treatment effects in women has prompted calls for more nuance in Alzheimer’s diagnosis and drug ...

Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...

A systematic review and meta-analysis finds that weight-loss interventions are associated with decreased psoriasis severity ...

The Defence Research and Development Organisation (DRDO) has achieved a major milestone with the successful completion of ...

VKTX remains a Buy for its cheap FY2030 EV/Sales valuations of 2.28x, the strong clinical trial results exceeding legacy ...

Getting paid to sleep sounds like a fantasy, but for a small and growing slice of the economy, rest itself is the product.

Is there a vaccine for the Nipah virus? Early human trials show a new vaccine is safe and triggers strong immune responses.

On November 24, Novo Nordisk announced that the GLP-1 mimetic semaglutide had failed to slow progression of Alzheimer’s disease in two Phase 3 trials. Even though the cat was out of the bag, ...

Diabetic kidney disease is a leading cause of kidney failure worldwide, yet current treatments often slow progression ...

President Donald Trump granted clemency to nearly 1,600 Jan. 6 defendants, cryptocurrency executive Changpeng Zhao, former ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...